Affordable Access

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.

Authors
Type
Published Article
Journal
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
1077-9450
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
20
Issue
3
Pages
245–254
Identifiers
PMID: 10077172
Source
Medline

Abstract

Statistics

Seen <100 times